Hepatitis Marker Screen–(HAV IgM, HBsAg, HCV Abs)
520,00 د.إSample Type : Serum
Methodology : Chemiluminescence
TAT : 1 Day
Showing 33–48 of 65 results

Sample Type : Serum
Methodology : Chemiluminescence
TAT : 1 Day

Sample Type : Serum
Methodology : Chemiluminescence+ELISA
TAT : 3 Days

Sample Type : Serum
Methodology : Chemiluminescence
TAT : 1 Day

Sample Type : Serum
Methodology : Chemiluminescence+ELISA
TAT : 3 Days

Sample Type : Serum
Methodology : Immunoblot
TAT : 4 Days

Sample Type : Serum
Methodology : Chemiluminescence
TAT : 1 Day

Sample Type : Serum
Methodology : Spectrophotometry
TAT : 1 Day

Sample Type : Serum
Methodology : Spectrophotometry
TAT : 1 Day

Sample Type : Serum
Methodology : Spectrophotometry
TAT : 1 Day

Sample Type : Serum
Methodology : Spectrophotometry
TAT : 1 Day

Sample Type : Serum
Methodology : Chemiluminescence
TAT : 1 Day

Sample Type : Spot Urine
Methodology :
TAT : 3 Weeks

Assess NK cell inhibition, lymphocyte differentiation (CD markers), NK cell toxicity, and TH1/TH2 cytokines to evaluate immune status and function.
Sample Type : Special Tubes
Methodology : NA
TAT : 15 Days

Sample Type : Serum
Methodology : NA
TAT : 14 Days

Sample Type : Serum
Methodology : ELISA
TAT : 4 Days

Sample Type : Whole Blood+Serum+Plasma+Urine
Methodology : NA
TAT : 1 Day